TOPICS: Asherman syndrome, overaggressive dilation and curettage, amenorrhea, pelvic pain, recurrent pregnancy loss, anovulatory cycle, estrogen, progesterone, oligomenorrhea, acute endometritis, bacterial infection, products of conception, abnormal uterine bleeding, chronic endometritis, lymphocytes, plasma cells, retained products of conception, chronic pelvic inflammatory disease, intrauterine devices, tuberculosis, endometriosis, retrograde menstruation, metaplastic transformation, lymphatic transport, gunpowder nodule, ovary, chocolate cysts, dysmenorrhoea, uterine ligaments, pelvic pain, fallopian tube mucosa, ectopic pregnancy, pouch of douglas, pain with defecation, bladder wall, pain with urination, infertility, risk of carcinoma, endometrial polyp, tamoxifen, endometrial hyperplasia, unopposed estrogen, obesity, polycystic ovarian syndrome, estrogen replacement therapy, granulosa cell tumor, anovulatory cycle, postmenopausal vaginal bleeding, atypia, endometrial carcinoma, sporadic, PTEN, mismatch repair proteins, early menarche, late menopause, nulliparity, infertility, obesity, endometrioid, atrophic endometrium, p53 mutation, papillary structures, psammoma bodies
